Status:
COMPLETED
Patient-Reported Preferences Affecting Revascularization Decisions
Lead Sponsor:
Duke University
Collaborating Sponsors:
Gilead Sciences
Conditions:
Coronary Artery Disease
Angina Pectoris
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Selection of a treatment strategy for patients with symptoms due to coronary artery disease requires consideration of patient preferences. In current clinical practice, patient preferences for treatme...
Detailed Description
Selecting a treatment strategy for patients with symptomatic coronary artery disease (CAD) requires integrated consideration of symptom burden, patient preferences, and practice guidelines. In many cl...
Eligibility Criteria
Inclusion
- Patients referred to the catheterization laboratory for diagnostic coronary angiography with a reasonable expectation of coronary artery disease, defined as chronic stable angina, chest pain with a positive functional study, unstable angina, or non-ST segment elevation myocardial infarction.
Exclusion
- Unable to provide informed consent
- Unable to speak or read English
- Critical illness
- When a delay in angiography to administer the decision aid could lead to adverse clinical outcome
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT02272062
Start Date
November 1 2014
End Date
June 1 2016
Last Update
August 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Hospital
Durham, North Carolina, United States, 27705